Maven Securities’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Maven Securities’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-150,000	Closed	-$20.7M	–	961
2020 Q3	$20.7M	Hold	150,000	–	–	1.7%	9
2020 Q2	$14.5M	Buy	+150,000	New	+$12.5M	0.99%	19
2019 Q2	–	Sell	-70,000	Closed	-$3.58M	–	107
2019 Q1	$3.58M	Buy	+70,000	New	+$3.22M	3.17%	9

Maven Securities's MYOK Position: Q4 2020 in Review

Maven Securities sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 150,000 shares — an estimated $20.7M sold.

Maven Securities first reported a position in MYOK in Q1 2019 and held it in 3 quarters. The position peaked at $20.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Maven Securities reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Maven Securities sold 150,000 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $20.7M.
Maven Securities first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Maven Securities's MyoKardia, Inc. Common Stock position peaked at $20.7M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.